s6y

8-K Current report filing

Filed
Period
Accession number
0001213900-26-050249

Documents

  1. CURRENT REPORT 8-K
  2. UNDERWRITING AGREEMENT BY AND AMONG ORUKA THERAPEUTICS, INC. AND LEERINK PARTNERS LLC, TD SECURITIES (USA) LLC, GOLDMAN SACHS & CO. LLC, STIFEL, NICOLAUS & COMPANY EX-1.1
  3. OPINION OF DAVIS POLK & WARDWELL LLP EX-5.1
  4. EXCERPT FROM PRELIMINARY PROSPECTUS SUPPLEMENT DATED APRIL 27, 2026 EX-99.1
  5. XBRL SCHEMA FILE EX-101.SCH
  6. XBRL LABEL FILE EX-101.LAB
  7. XBRL PRESENTATION FILE EX-101.PRE

On sec.gov